Drug Database
NI

nicotinic acid (nicotinic acid ER / Niaspanor / Niaspan)

✓ Approved

Merck KGaA · HCAR2 · 小分子

什么是 nicotinic acid?

nicotinic acid 是一种小分子,由Merck KGaA研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名nicotinic acid ER, Niaspanor, Niaspan
公司Merck KGaA
药物类别小分子
分子靶点HCAR2
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

nicotinic acid 作用于 1 个分子靶点:

HCAR2hydroxycarboxylic acid receptor 2 (NIACR1, GPR109A)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

nicotinic acid 针对 8 个适应症,涉及 4 个治疗领域。

治疗领域疾病/病症分期
Vascular disordersArteriosclerosis✓ Approved
Metabolism and nutrition disordersHypercholesterolaemia✓ Approved
Metabolism and nutrition disordersHypertriglyceridaemia✓ Approved
Cardiac disordersMyocardial infarction✓ Approved
Metabolism and nutrition disordersDyslipidaemia✓ Approved

注册免费账户还可查看另外 3 个适应症

免费注册查看全部适应症 →

相关研究文献

PubMedAnimal microbiome2026-11-19

Dose-dependent microbiome, metabolome and lipidome shifts in a mouse model of colitis-associated colorectal cancer using azoxymethane and dextran sodium sulphate.

Van Dingenen Lena L, Segers Charlotte C, Mysara Mohamed M, Osang'ir Bernard Isekah BI et al.

Colorectal cancer (CRC) remains a major health burden, underscoring the need for continued research to improve screening methods and treatment outcomes. The colitis-associated azoxymethane (AOM) and dextran sodium sulphate (DSS) mouse model has proven valuable for CRC research, as it closely mimics human CRC development and captures the complex interactions between the gut microbiome and immune system. However, variations in AOM/DSS dosing reported in literature can influence baseline conditions, thereby affecting the outcome and interpretation of experimental and therapeutic interventions. This study evaluated the impact of varying AOM and DSS doses on CRC development and the gut microbiome, metabolome and lipidome in mouse faeces (n = 29). Inflammation-driven CRC progression was more pronounced in mice treated with high-dose AOM (12.5 mg/kg) combined with high-dose DSS (2%) than in those receiving lower doses. Faecal 16S rRNA-based microbiome analysis revealed significant shifts in the high-dose AOM groups, which coincided with the highest tumour burden. Operational taxonomic units (OTUs) belonging to Prevotella, Turicibacter, Intestinimonas and Akkermansia muciniphila displayed patterns linked to inflammation and tumour progression, with distinct temporal abundance increases across AOM/DSS dosing groups. State-of-the-art, validated UHPLC-HRMS methodologies for faecal metabolomics and lipidomics fingerprinting (7951 features) and profiling (202 targets) identified imidazolepropionic acid, a microbe-derived metabolite, as a candidate biomarker associated with inflammation-driven CRC. In addition, mice with a high tumour burden presented elevated levels of lactic acid and γ-glutamylphenylalanine as well as decreased levels of fumaric acid, 6-deoxygalactose, glucosamine/mannosamine and L-threonine, all of which are associated with gut barrier dysfunction and inflammation. Furthermore, there was a decreased abundance of a short-chain acylcarnitine and both odd-chain and even-chain fatty acids, suggesting that altered energy metabolism may be associated with CRC progression. Multi-omics integration revealed a factor shaped by differential contributions from metabolites and lipids linked to Lachnospiraceae spp., with compounds like lactic acid, methylmalonic acid, linoleic acid and palmitoleic acid positively associated with inflammation and CRC, while hypoxanthine, nicotinic acid/2-picolinic acid, L-carnitine and deoxycarnitine, showed potential protective associations. These findings highlight the complex interplay between gut inflammation, microbiome dynamics and metabolic reprogramming in CRC and suggest that AOM/DSS dosing substantially influences these interactions.

PMID 43053245
阅读全文 →
PubMedBrain and behavior2026-11-19

Neuroprotective Mechanisms of Electroacupuncture at Baihui (GV20) in Experimental Ischemic Stroke: A Narrative Review.

Zhang Shuo S, Cui Yang Y, Zhou Xinyu X, Wang Delong D et al.

Ischemic stroke is a major cause of death and disability, and reperfusion therapy has a narrow time window and may cause further injury after recanalization. Baihui (GV20) is the acupoint used most often in experimental studies of acupuncture for stroke, and electroacupuncture (EA) at GV20, applied alone or combined with other acupoints, has been tested in a large body of animal work. Taking GV20 as its organizing focus, this review systematically summarizes the mechanisms by which GV20-based EA protects against ischemic stroke in animal models. GV20-based EA has been reported to reduce neuroinflammation through the α7 nicotinic acetylcholine receptor-high-mobility group box 1 pathway, nuclear factor-κB and inflammasome signaling, and glial responses; to prevent apoptosis, pyroptosis, and ferroptosis and engage adenosine A1 receptor signaling; to preserve mitochondrial dynamics, energy metabolism, and redox balance; to protect the blood-brain barrier and promote cerebral perfusion and angiogenesis; and to enhance neurotrophic signaling, synaptic plasticity, and white matter repair. GV20 alone has been studied mainly as preconditioning, and GV20-based combinations have been applied primarily after ischemia; the effects on hypoxia-inducible factor-1α, autophagy, and microglial polarization vary with the timing of EA and assessment. Because these findings derive largely from young, healthy rodents and most mechanistic results are based on changes in expression, they do not yet support direct clinical application; future studies should compare GV20 alone with GV20-based combinations under the same conditions and validate key mechanisms with causal designs in clinically relevant models.

PMID 43053462
阅读全文 →
PubMedJournal of translational medicine2026-11-19

Metabolic remodeling in early- and late-onset colorectal cancer supports an age-informed detection model.

Wang Ruowei R, Wang Weifeng W, Liao Leen L, Zheng Muxu M et al.

The incidence of early-onset colorectal cancer (EOCRC) has increased in recent decades; however, most metabolomic studies have focused on all age groups. Consequently, it remains uncertain how metabolic alterations drive EOCRC progression and whether biomarker signatures identified in older patients are valid in younger populations. We performed untargeted plasma metabolomic profiling of 791 participants, including those with colorectal cancer (CRC), colorectal adenoma (CRA), and healthy controls. Individuals were stratified by age (<50 and ≥50 years) to explore metabolic remodeling during EOCRC and late-onset CRC (LOCRC) development. A multistep feature selection process and 12 machine learning algorithms were used to establish an age-informed CRC detection model. CRC progression was associated with the suppression of caffeine and histidine metabolism and the enhancement of amino acid metabolism, particularly branched-chain amino acid, glycine-serine, and arginine-proline pathways. EOCRC showed increased phenylalanine, butanoate, and lipoic acid metabolism, whereas LOCRC was enriched in purine and fatty acid biosynthesis. A 7-metabolite panel (caffeine, ergothioneine, hypoxanthine 1, L-valyl-L-alanine, L-seryl-L-aspartic acid, cholic acid, and cycloleucine) was trained and achieved excellent detection values in all age groups (AUC > 0.95). SHapley Additive exPlanations (SHAP) analysis highlighted metabolite-specific contributions, supporting biological interpretability. These findings delineate age-related metabolic remodeling in CRC and demonstrate that integrating plasma metabolomics with machine learning supports a robust and interpretable non-invasive detection approach. The proposed age-informed model may inform future age-tailored CRC detection strategies amid the increasing burden of early-onset cancers.

PMID 43053157
阅读全文 →
PubMedNature communications2026-11-19

Metabolic engineering and deep learning-driven protein engineering for N-Acetylneuraminic acid biosynthesis in Escherichia coli.

Wang Nan-Kai NK, Yue Song S, Chen Jin-Ping JP, Su Chang C et al.

N-Acetylneuraminic acid (NeuAc) is a sialic acid valued in pharmaceuticals and infant nutrition, and microbial synthesis offers a scalable route once the pathway's catalytic bottlenecks are relieved. We combine deep learning with metabolic engineering to build a high-titer NeuAc-producing E.coli strain. Modular pathway engineering reaches 1.25 g L-1 and pinpoints N-acetylglucosamine 2-epimerase (AGE) as the rate-limiting step. We develop DLCatalysis, a deep learning framework that predicts kcat Km-1 directly from protein sequence and substrate, and use it to mine AGEBf that lifts the titer to 6.84 g L-1. DLCatalysis-guided redesign of AGEBf and NeuBNm raises NeuAc to 9.27 g L⁻¹, and identifying and deleting exuT, a previously unannotated NeuAc transporter, blocks product reuptake. In 5-L fed-batch fermentation the optimized strain produces 85.5 g L-1, showing that AI-guided enzyme discovery can resolve the bottlenecks that have limited microbial NeuAc production.

PMID 43052267
阅读全文 →
PubMedWorld journal of gastrointestinal oncology2026-11-19

Correction to "Impact of Alcian blue and periodic acid Schiff expression on the prognosis of gastric signet ring cell carcinoma".

Lin Juan J, Chen Zhu-Feng ZF, Guo Guo-Dong GD, Chen Xin X

[This corrects the article DOI: 10.4251/wjgo.v16.i3.687.].

PMID 43053751
阅读全文 →
PubMednpj aging2026-11-19

FGF21-dependent and -independent liver transcriptomic adaptations to low-protein feeding during aging.

Godoy-Lugo Jose A JA, Young Khristina E KE, Vaddi Prerana P, Albarado Diana C DC et al.

Aging is a risk factor for the development and progression of metabolic impairments. Dietary protein restriction (DPR) is protective against obesity- and age-related metabolic decline by the induction of the fibroblast growth factor (FGF21), which regulates body weight, lipid handling, and energy expenditure. Likewise, FGF21 is established as an endocrine mediator that responds to multiple nutritional inputs, including carbohydrate overload, protein restriction, prolonged fasting, and excess alcohol intake. Here, we show that long-term protein restriction differentially enriches hepatic transcriptomic pathways, that reprograms and regulates energy production and metabolism. Interestingly, both genotypes revealed to have enriched processes of amino acid metabolism and translation. Comparisons among low protein-fed C57BL/6 and Fgf21 knockout mice show inverse enrichment for biological processes of monocarboxylic acid, lipid metabolic processes, with fatty acid metabolic process showing genotype differences in cluster analysis. Exclusively, DPR upregulated hepatic signatures related to ATP synthesis in aged C57BL/6, which were not observed in mice deficient of FGF21 signaling. These data suggest that key long-term metabolic adaptations to protein restriction develop through differential FGF21-dependent and independent pathways, which may contribute to the improved systemic healthspan and lifespan observed with protein-restricted diets.

PMID 43052271
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多nicotinic acid